- Net Income: EU1.48 billion, down 35% year-over-year; missed the estimate of EU2.12 billion.
- Recurring Operating Income: EU3.12 billion, down 6.9% year-over-year; narrowly beat the estimate of EU3.11 billion.
- Organic Growth in Profit: Increased by 2%, exceeding the estimate of 0.56%.
- Sales: EU11.60 billion, a decline of 4.4% year-over-year; fell short of the estimate of EU11.69 billion.
- Advertising & Promotional Expenses: EU1.87 billion, down 3.5% year-over-year; slightly below the estimate of EU1.9 billion.
- Recurring Net Income: EU2.00 billion, a decrease of 15% year-over-year; missed the estimate of EU2.04 billion.
- Dividend per Share: EU4.70, higher than the estimate of EU4.43.
- Free Cash Flow: EU963 million, down 33% year-over-year; below the estimate of EU1.09 billion.
- Net Debt: EU10.95 billion, increased by 6.6% year-over-year; higher than the estimate of EU10.67 billion.
- Fourth Quarter Sales: EU2.66 billion, up 1.2% year-over-year; missed the estimate of EU2.74 billion.
- Americas Sales: EU766 million, up 5.2% year-over-year; slightly below the estimate of EU769 million.
- Asia, Rest of World Sales: EU1.11 billion, up 3.2% year-over-year; missed the estimate of EU1.17 billion.
- Europe Sales: EU789 million, down 4.8% year-over-year; below the estimate of EU809.5 million.
- Organic Sales: Increased by 3%, slightly below the estimate of 3.24%.
- Americas Organic Sales: Up by 5%, significantly above the estimate of -0.63%.
- Asia, Rest of World Organic Sales: Up by 7%, slightly below the estimate of 7.74%
- Europe Organic Sales: Down 5%, significantly below the estimate of -2.45%.
- Forex Impact: -3%, higher than the estimate of -2.03%.
- Future Outlook:
- Confirms medium-term financial framework of upper end of +4% to +7% organic net sales growth.
- Expects organic operating margin expansion of +50bps to +60bps.
- Sees FY organic net sales back to growth with continued volume recovery.
- Predicts a soft 1Q due to further inventory adjustments in the US and weak macro context in China.
- Non-recurring operating expenses include wine business impairment, partially mitigated by proceeds on disposals and reversal of impairment on Kahlúa.
A look at Pernod Ricard Sa Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Smartkarma Smart Scores indicate a mixed long-term outlook for Pernod Ricard SA, a company that produces wines and spirits. With a Value score of 3, the company is viewed neutrally in terms of its stock valuation. Pernod Ricard receives a strong score of 4 in both Dividend and Growth categories, suggesting a positive outlook for income generation and future expansion. However, its Resilience and Momentum scores of 3 and 2 respectively signal moderate performance in these areas. Overall, the Smart Scores portray Pernod Ricard as a stable company with growth potential, supported by its commitment to dividends and ongoing development.
Pernod Ricard SA, known for its wide range of wines, bitters, whiskies, liqueurs, and more, has a global market presence. The company’s Smartkarma Smart Scores provide insights into its investment attractiveness. While excelling in Dividend and Growth metrics, Pernod Ricard’s performance in terms of Resilience and Momentum is moderate. This nuanced evaluation suggests a balanced outlook for the company in the long term, with strengths in income generation and growth offset by areas where improvement may be sought. Investors may consider Pernod Ricard as a stable option with opportunities for expansion in the dynamic wines and spirits industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
